The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$5.32

Today's change-0.01 -0.19%
Updated May 27 3:26 PM EDT. Delayed by at least 15 minutes.
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$5.32

Today's change-0.01 -0.19%
Updated May 27 3:26 PM EDT. Delayed by at least 15 minutes.

Aralez Pharmaceuticals Inc down $0.01

Aralez Pharmaceuticals Inc closed lower Friday, dropping $0.01 or 0.19% to $5.32. Over the last five days, shares have gained 4.52% and 300.00% year to date. Shares have outperformed the S&P TSX by 332.25% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.52
Updated May 27 3:26 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-176.63%

Aralez Pharmaceuticals Inc has a net profit margin of -176.63%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.40%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue6654
Total other revenue--------
Total revenue6654
Gross profit--------
Total cost of revenue--------
Total operating expense2014204
Selling / general / administrative1712183
Research & development3221
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-14-8-150
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-14-8-150
Income after tax-13-8-160
Income tax, total-1010
Net income-13-8-160
Total adjustments to net income--------
Net income before extra. items-13-8-160
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-13-8-160
Inc. avail. to common incl. extra. items-13-8-160
Diluted net income-13-8-160
Dilution adjustment------0
Diluted weighted average shares33333232
Diluted EPS excluding extraordinary itemsvalue per share-0.40-0.25-0.500.00
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.40-0.25-0.500.00
R